Combinatorial Synthesis of Transition State Mimetic Inhibitor Using Asymmetric Aldol, Reaction
Combinatorial Synthesis of Transition State Mimetic Inhibitor Using Asymmetric Aldol, Reaction
批准号:
13672211
负责人:
AKAJI Kenichi
金额:
$2.24万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2002
中文摘要
点击翻译按钮获取中文摘要
英文摘要
An efficient method has been developed for the first solid phase synthesis of HTLV 1 protease inhibitors that contain hydroxyethylamine isostere as transitionslate mimetic. The synthetic procedure was designed to allow the evaluation of stereostmctureactivity relationships at the scissile site. All the possible configurations at the hydroxy and side chainbearing asymmetric centers of the isostere were constructed by an esterderived asymmetric aldol reaction. Each inhibitor containing the isostere backbone was synthesized on solid support using the newly developed succinate ester linker. The configuration at the hydroxy and side chainbearing asymmetric center showed remarkable effects on the inhibitory activity. The K_i value changed with approximately two orders of magnitude. This approach enables an efficient preparation of the inhibitors containing a transitionstate mimetic
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
K,Akaji, K,Teraya, S,Aimoto: "Stereoselective synthesis and evaluation of HTLV-1 protease inhibitors"Peptide Scaerice 2002. 37-40 (2003)
K,Akaji,K,Teraya,S,Aimoto:“HTLV-1蛋白酶抑制剂的立体选择性合成和评价”Peptide Scaerice 2002. 37-40 (2003)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
K.Teruya, T.Kawakami, K.Akaji, S.Aimoto: "Synthesis of [L40I, C90A, C109A]-human T-cell leukemia virus-type 1 protease"Tetrahedron Letters. (in press).
K.Teruya、T.Kawakami、K.Akaji、S.Aimoto:“[L40I、C90A、C109A]-人 T 细胞白血病病毒 1 型蛋白酶的合成”四面体字母。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
K.Teruya, T.Kawakami, K.Akaji, S.Aimoto: "Total synthesis of [L40I, C9OA, C109A]-human T-cell leukemia virus type 1 protease"Tetrahedron Letters. 43. 1487-1490 (2002)
K.Teruya、T.Kawakami、K.Akaji、S.Aimoto:“[L40I、C9OA、C109A]-人 T 细胞白血病病毒 1 型蛋白酶的全合成”四面体字母。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
K.Akaji, K.Teruya, S.Aimoto: "Stereoselective synthesis and evaluation of HTLV-1 protease inhibitors"Peptide Science 2002. 2002. 37-40 (2003)
K.Akaji、K.Teruya、S.Aimoto:“HTLV-1蛋白酶抑制剂的立体选择性合成和评价”肽科学2002. 2002. 37-40 (2003)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
K.Akaji, K.Teruya, S.Aimoto: "Solid-phase synthesis of HTLV-1 protease inhibitors containing hydroxyethylamine dipeptide isostere"Journal of the Organic Chemistry. 2003(In press). (2003)
K.Akaji、K.Teruya、S.Aimoto:“含羟乙胺二肽电子等排体的 HTLV-1 蛋白酶抑制剂的固相合成”有机化学杂志。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 10 条
Development of a novel persistent protease inhibitor containing D-amino acid
-
批准号:21590017
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.0万
-
财政年份:2009
-
负责人:AKAJI Kenichi
-
依托单位:
Development of SARS virus inhibitor using unusual amino acid-containing natural products as seeds
-
批准号:18590010
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.44万
-
财政年份:2006
-
负责人:AKAJI Kenichi
-
依托单位:
Intramolecularcyclization by solid-phase olefination and its application to combinatorial synthesis
-
批准号:10557210
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$3.65万
-
财政年份:1998
-
负责人:AKAJI Kenichi
-
依托单位:
Convergent synthesis and SAR of dolastatin 15 by solid phase coupling
-
批准号:10672011
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:1998
-
负责人:AKAJI Kenichi
-
依托单位:
Convergent Synthesis of Anti-Cancer Alkaloid, Mirabazols, using a New Coupling Reagent
-
批准号:08672459
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.6万
-
财政年份:1996
-
负责人:AKAJI Kenichi
-
依托单位:
Development of Low Molecular Weight HIV Protease Inhibitor for Oral Use
-
批准号:07557141
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$3.78万
-
财政年份:1995
-
负责人:AKAJI Kenichi
-
依托单位:
海外基金